{"id":"https://openalex.org/W2071015683","doi":"https://doi.org/10.1021/jm030427r","title":"Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure\u2212Activity Relationships, and Antitumor Activities of N-Phenyl-N\u2018-{4-(4-quinolyloxy)phenyl}ureas","display_name":"Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure\u2212Activity Relationships, and Antitumor Activities of N-Phenyl-N\u2018-{4-(4-quinolyloxy)phenyl}ureas","publication_year":2005,"publication_date":"2005-02-15","ids":{"openalex":"https://openalex.org/W2071015683","doi":"https://doi.org/10.1021/jm030427r","mag":"2071015683","pmid":"https://pubmed.ncbi.nlm.nih.gov/15743179"},"language":"en","primary_location":{"id":"doi:10.1021/jm030427r","doi":"https://doi.org/10.1021/jm030427r","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm030427r","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062150969","display_name":"Kazuo Kubo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kazuo Kubo","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014507741","display_name":"Toshiyuki Shimizu","orcid":"https://orcid.org/0000-0002-0547-8922","observed_orcids":["https://orcid.org/0000-0002-0547-8922"]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiyuki Shimizu","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016205861","display_name":"Shin-ichi Ohyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-ichi Ohyama","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023129761","display_name":"Hideko Murooka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideko Murooka","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111809299","display_name":"Akemi Iwai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akemi Iwai","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050476600","display_name":"Kazuhide Nakamura","orcid":"https://orcid.org/0000-0002-5155-1932","observed_orcids":["https://orcid.org/0000-0002-5155-1932"]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhide Nakamura","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111938262","display_name":"Kazumasa Hasegawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazumasa Hasegawa","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084424510","display_name":"Yoshiko Kobayashi","orcid":"https://orcid.org/0000-0003-0547-6078","observed_orcids":["https://orcid.org/0000-0003-0547-6078"]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiko Kobayashi","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035038653","display_name":"Noriko K. Takahashi","orcid":"https://orcid.org/0000-0003-1025-1690","observed_orcids":["https://orcid.org/0000-0003-1025-1690"]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Takahashi","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102122249","display_name":"Kazumi Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazumi Takahashi","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052304709","display_name":"Shinichiro Kato","orcid":"https://orcid.org/0000-0002-4691-8322","observed_orcids":["https://orcid.org/0000-0002-4691-8322"]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichiro Kato","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103640761","display_name":"Toshio Izawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Izawa","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081770697","display_name":"Toshiyuki Isoe","orcid":"https://orcid.org/0000-0001-9449-7692","observed_orcids":["https://orcid.org/0000-0001-9449-7692"]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiyuki Isoe","raw_affiliation_strings":["Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development Laboratories, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062150969"],"corresponding_institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.5486,"has_fulltext":false,"cited_by_count":153,"citation_normalized_percentile":{"value":0.80465656,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"48","issue":"5","first_page":"1359","last_page":"1366"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.8906000256538391,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.8906000256538391,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.10540000349283218,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vegfr-2-inhibitors","display_name":"VEGFR-2 inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8040000200271606},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7089999914169312},{"id":"https://openalex.org/keywords/c-kit-inhibition","display_name":"c-kit inhibition","score":0.9860000014305115},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8809999823570251},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.8339999914169312},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.7839999794960022},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7757974863052368},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6107389330863953},{"id":"https://openalex.org/C2777411675","wikidata":"https://www.wikidata.org/wiki/Q1232438","display_name":"Umbilical vein","level":3,"score":0.5397918820381165},{"id":"https://openalex.org/C2778866207","wikidata":"https://www.wikidata.org/wiki/Q426278","display_name":"Quinazoline","level":2,"score":0.5209585428237915},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4922691881656647},{"id":"https://openalex.org/C2777847059","wikidata":"https://www.wikidata.org/wiki/Q6537255","display_name":"Lewis lung carcinoma","level":4,"score":0.4920065104961395},{"id":"https://openalex.org/C14858245","wikidata":"https://www.wikidata.org/wiki/Q18028241","display_name":"Kinase insert domain receptor","level":5,"score":0.4822833836078644},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4695570766925812},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4440919756889343},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.43848860263824463},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.43694204092025757},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.435300350189209},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4155055582523346},{"id":"https://openalex.org/C2777553839","wikidata":"https://www.wikidata.org/wiki/Q14330986","display_name":"Tyrosine phosphorylation","level":3,"score":0.4123848080635071},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3867625594139099},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3715476393699646},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.3682568073272705},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31311121582984924},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29935258626937866},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.2685682773590088},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26792508363723755},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.2390425205230713},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.23692739009857178},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.22943809628486633},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.190119206905365},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.1148688793182373},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11463424563407898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.10187363624572754}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014471","descriptor_name":"Umbilical Veins","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040301","descriptor_name":"Vascular Endothelial Growth Factor Receptor-2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm030427r","doi":"https://doi.org/10.1021/jm030427r","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm030427r","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15743179","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15743179","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1964203908","https://openalex.org/W1973319649","https://openalex.org/W2010706089","https://openalex.org/W2015809080","https://openalex.org/W2042649794","https://openalex.org/W2054979979","https://openalex.org/W2058413420","https://openalex.org/W2066498455","https://openalex.org/W2067458955","https://openalex.org/W2075578776","https://openalex.org/W2115050780","https://openalex.org/W2155591132","https://openalex.org/W2164470179","https://openalex.org/W2313417051"],"related_works":["https://openalex.org/W1984316153","https://openalex.org/W2078364138","https://openalex.org/W97211951","https://openalex.org/W2263889036","https://openalex.org/W4309368421","https://openalex.org/W4401834408","https://openalex.org/W2059732801","https://openalex.org/W2098429463","https://openalex.org/W2086049376","https://openalex.org/W3210842640"],"abstract_inverted_index":{"N-Phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas":[0],"were":[1],"found":[2],"to":[3],"be":[4],"a":[5,26,104,154],"novel":[6],"class":[7],"of":[8,25,46,94],"potent":[9],"inhibitors":[10],"for":[11,156],"the":[12,52,92,95,144],"vascular":[13],"endothelial":[14,100],"growth":[15,93,141],"factor":[16],"receptor":[17],"2":[18],"(VEGFR-2)":[19],"tyrosine":[20],"kinase":[21],"through":[22],"synthetic":[23],"modifications":[24],"lead":[27],"compound":[28,35],"and":[29,49,59,64,84,130,136],"structure-activity":[30],"relationship":[31],"studies.":[32],"A":[33],"representative":[34],"6ab,":[36],"termed":[37],"Ki8751,":[38],"inhibited":[39,51],"VEGFR-2":[40],"phosphorylation":[41],"at":[42,61,87,159],"an":[43],"IC(50)":[44],"value":[45],"0.90":[47],"nM,":[48,66],"also":[50,137],"PDGFR":[53],"family":[54],"members":[55],"such":[56,79,117],"as":[57,80,118],"PDGFRalpha":[58],"c-Kit":[60],"67":[62],"nM":[63],"40":[65],"respectively.":[67],"However,":[68],"6ab":[69,90,107],"did":[70],"not":[71],"have":[72],"any":[73,163],"inhibitory":[74],"activity":[75,111],"against":[76,112],"other":[77],"kinases":[78],"EGFR,":[81],"HGFR,":[82],"InsulinR":[83],"others":[85],"even":[86],"10000":[88],"nM.":[89],"suppressed":[91],"VEGF-stimulated":[96],"human":[97,114],"umbilical":[98],"vein":[99],"cell":[101],"(HUVEC)":[102],"on":[103],"nanomolar":[105],"level.":[106],"showed":[108,138],"significant":[109],"antitumor":[110],"five":[113],"tumor":[115,140],"xenografts":[116],"GL07":[119],"(glioma),":[120],"St-4":[121],"(stomach":[122],"carcinoma),":[123,126],"LC6":[124],"(lung":[125],"DLD-1":[127],"(colon":[128],"carcinoma)":[129],"A375":[131],"(melanoma)":[132],"in":[133,147],"nude":[134,148],"mice":[135],"complete":[139],"inhibition":[142],"with":[143],"LC-6":[145],"xenograft":[146],"rats":[149],"following":[150],"oral":[151],"administration":[152],"once":[153],"day":[155],"14":[157],"days":[158],"5":[160],"mg/kg":[161],"without":[162],"body":[164],"weight":[165],"loss.":[166]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}